- Home
- VCEL vs IMOS Comparison
VCEL vs IMOS Comparison
Compare VCEL & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | IMOS |
|---|---|---|
| Founded | 1989 | 1997 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VCEL | IMOS |
|---|---|---|
| Price | $38.27 | $55.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.75 | N/A |
| AVG Volume (30 Days) | ★ 428.3K | 52.8K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | $21.75 |
| Revenue Next Year | $18.24 | $4.21 |
| P/E Ratio | ★ N/A | $158.35 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $18.00 |
| 52 Week High | $49.32 | $78.35 |
Technical Indicators
Market Signals| Indicator | VCEL | IMOS |
|---|---|---|
| Relative Strength Index (RSI) | 27.12 | 48.90 |
| Support Level | $35.45 | $55.07 |
| Resistance Level | $38.01 | $58.04 |
| Average True Range (ATR) | 1.12 | 1.54 |
| MACD | -0.34 | 0.32 |
| Stochastic Oscillator | 1.38 | 58.29 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.